China NMPA Inspection - Fuzhou Zhangfei Yijue Industrial Development Co., Ltd. - September 01, 2021

The Jiangxi Provincial Drug Administration issued an announcement on September 1, 2021, detailing the results of a supervision and inspection of Fuzhou Zhangfei Yijue Industrial Development Co., Ltd. The inspection, conducted on July 28, 2021, was initiated following the company's application to resume its manufacturing operations. An inspection team from the Provincial Administration performed an on-site assessment to verify the company's adherence to regulatory standards. The review concluded that Fuzhou Zhangfei Yijue Industrial Development Co., Ltd. largely complies with the "Cosmetics Production Licensing Work Specifications." This positive finding led to the official approval for the company to recommence its production activities, indicating that no significant violations were identified that would impede its resumption. In line with this approval, the company is reminded of its ongoing obligations. It is required to strictly observe all applicable laws and regulations, diligently strengthen its production quality management processes, and actively fulfill its primary responsibility for ensuring the safety of cosmetic products. This regulatory action by the Jiangxi Provincial Drug Administration, under the broader National Medical Products Administration (NMPA) framework, emphasizes the continuous oversight required for maintaining high standards in cosmetics manufacturing and safeguarding public health.